Received Dec 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | — |
faint; The spontaneous report was received from a nurse via a company representative referring to a Adolescent patient of unknown gender. The patient's pertinent medical history, concurrent conditions, concomitant therapy, drug Reactions and allergies were not reported. On an unknown date, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL9) for prophylaxis (strength, dose, route, lot # and expiration date were not reported). On an unknown date, the patient experienced faint following Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL9) injection. At the reporting time, the outcome of faint was unknown. The action taken with Human Papillomavirus 9-valent Vaccine, Recombinant was not applicable. No specific patient information provided. The causal relationship between the event of faint and Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL9) was unknown. Upon internal review, the event of faint was determined to be medically significant. This is one of five reports from the same reporter.